Wedbush Starts Kinnate Biopharma (KNTE) at Outperform

December 28, 2020 6:44 AM EST
Get Alerts KNTE Hot Sheet
Price: $21.76 +0.14%

Rating Summary:
    5 Buy, 0 Hold, 0 Sell

Rating Trend: = Flat

Today's Overall Ratings:
    Up: 18 | Down: 11 | New: 8
Trade Now! 
Join SI Premium – FREE

Wedbush analyst David Nierengarten initiates coverage on Kinnate Biopharma (NASDAQ: KNTE) with a Outperform rating.

For an analyst ratings summary and ratings history on Kinnate Biopharma click here. For more ratings news on Kinnate Biopharma click here.

Shares of Kinnate Biopharma closed at $38.00 yesterday.

You May Also Be Interested In

Related Categories

New Coverage